Infection control recommendations for patients with cystic fibrosis: microbiology, important pathogens, and infection control practices to prevent patient-to-patient transmission. (Q51669881)

From Wikidata

Jump to navigation Jump to search

scientific article published in May 2003

Language	Label	Description	Also known as
English	Infection control recommendations for patients with cystic fibrosis: microbiology, important pathogens, and infection control practices to prevent patient-to-patient transmission.	scientific article published in May 2003

Statements

scholarly article

1 reference

Europe PubMed Central

9 April 2018

http://europepmc.org/abstract/MED/12789902

1 reference

Europe PubMed Central

Infection control recommendations for patients with cystic fibrosis: microbiology, important pathogens, and infection control practices to prevent patient-to-patient transmission. (English)

1 reference

Europe PubMed Central

9 April 2018

http://europepmc.org/abstract/MED/12789902

cystic fibrosis

0 references

0 references

author name string

Lisa Saiman

1

1 reference

Europe PubMed Central

9 April 2018

http://europepmc.org/abstract/MED/12789902

Jane Siegel

2

1 reference

Europe PubMed Central

9 April 2018

http://europepmc.org/abstract/MED/12789902

Cystic Fibrosis Foundation

3

1 reference

Europe PubMed Central

9 April 2018

http://europepmc.org/abstract/MED/12789902

publication date

1 May 2003

1 reference

Europe PubMed Central

9 April 2018

http://europepmc.org/abstract/MED/12789902

Infection Control and Hospital Epidemiology

1 reference

Europe PubMed Central

9 April 2018

http://europepmc.org/abstract/MED/12789902

24

1 reference

Europe PubMed Central

9 April 2018

http://europepmc.org/abstract/MED/12789902

5 Suppl

1 reference

Europe PubMed Central

9 April 2018

http://europepmc.org/abstract/MED/12789902

S6-52

1 reference

Europe PubMed Central

9 April 2018

http://europepmc.org/abstract/MED/12789902

Prospective comparison of risk factors and demographic and clinical characteristics of community-acquired, methicillin-resistant versus methicillin-susceptible Staphylococcus aureus infection in children

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Staphylococcus aureus infections

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Persistence of Staphylococcus aureus strains among cystic fibrosis patients over extended periods of time

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Nasal carriage as a source of Staphylococcus aureus bacteremia. Study Group

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Use of a Staphylococcus aureus conjugate vaccine in patients receiving hemodialysis.

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Cystic fibrosis epithelial cells have a receptor for pathogenic bacteria on their apical surface

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Anaerobic conditions induce expression of polysaccharide intercellular adhesin in Staphylococcus aureus and Staphylococcus epidermidis

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Antibiotic prophylaxis in infants and young children with cystic fibrosis: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Management of pulmonary disease in patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Methicillin resistant Staphylococcus aureus (MRSA) infection in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Factors influencing outcomes in cystic fibrosis: a center-based analysis.

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus.

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

An organizational climate intervention associated with increased handwashing and decreased nosocomial infections.

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Behavioral interventions to improve infection control practices

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Effectiveness of a hospital-wide programme to improve compliance with hand hygiene. Infection Control Programme

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Control of vancomycin-resistant enterococcus in health care facilities in a region.

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Prevention of nosocomial respiratory syncytial virus infections through compliance with glove and gown isolation precautions

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Nosocomial respiratory syncytial virus infections: the cost-effectiveness and cost-benefit of infection control

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Control of vancomycin-resistant enterococci at a community hospital: efficacy of patient and staff cohorting.

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Multiple Isolates of Pseudomonas aeruginosa with Differing Antimicrobial Susceptibility Patterns from Patients with Cystic Fibrosis

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

To gown or not to gown: the effect on acquisition of vancomycin-resistant enterococci

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Effectiveness of contact isolation during a hospital outbreak of methicillin-resistant Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Management of Pseudomonas aeruginosa lung infection in Danish cystic fibrosis patients.

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Estimated risk of cross-infection with Pseudomonas aeruginosa in Danish cystic fibrosis patients.

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Prevention of chronic Pseudomonas aeruginosa colonisation in cystic fibrosis by early treatment

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Outbreak of Campylobacter food-poisoning in Northern Ireland

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Epidemiology of Pseudomonas cepacia in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Microbiological processing of respiratory specimens from patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Pseudomonas cepacia colonization in patients with cystic fibrosis: risk factors and clinical outcome

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Burkholderia cepacia. Management issues and new insights.

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Disinfection of respirator tubing: a comparison of chemical versus hot water machine-assisted processing

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Selective media for the quantitation of bacteria in cystic fibrosis sputum.

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Early pulmonary infection, inflammation, and clinical outcomes in infants with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Antimicrobial activity of home disinfectants and natural products against potential human pathogens

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Microbiology of airway disease in patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Effects of sodium bicarbonate, vinegar, acetic and citric acids on growth and survival of Yersinia enterocolitica

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Burkholderia cepacia lower respiratory tract infection associated with exposure to a respiratory therapist

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Persistence and variability of Stenotrophomonas maltophilia in cystic fibrosis patients, Madrid, 1991-1998.

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Use of random amplified polymorphic DNA PCR to examine epidemiology of Stenotrophomonas maltophilia and Achromobacter (Alcaligenes) xylosoxidans from patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

An epidemic spread of multiresistant Pseudomonas aeruginosa in a cystic fibrosis centre

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Pseudomonas cepacia in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Superinfection with a transmissible strain of Pseudomonas aeruginosa in adults with cystic fibrosis chronically colonised by P aeruginosa

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Candida osteomyelitis and diskitis after spinal surgery: an outbreak that implicates artificial nail use.

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Postoperative Serratia marcescens wound infections traced to an out-of-hospital source.

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Guideline for infection control in healthcare personnel, 1998

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Spread of a multiresistant strain of Pseudomonas aeruginosa in an adult cystic fibrosis clinic.

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Burkholderia ambifaria sp. nov., a novel member of the Burkholderia cepacia complex including biocontrol and cystic fibrosis-related isolates

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Burkholderia cepacia genomovar VI, a new member of the Burkholderia cepacia complex isolated from cystic fibrosis patients

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Polyphasic Taxonomy in the Genus Burkholderia Leading to an Emended Description of the Genus and Proposition of Burkholderia vietnamiensis sp. nov. for N2-Fixing Isolates from Rice in Vietnam

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Spread of beta-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic.

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Infection withBurkholderia cepaciaComplex Genomovars in Patients with Cystic Fibrosis: Virulent Transmissible Strains of Genomovar III Can ReplaceBurkholderia multivorans

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Occurrence of multiple genomovars of Burkholderia cepacia in cystic fibrosis patients and proposal of Burkholderia multivorans sp. nov.

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Misidentification of Burkholderia cepacia in US cystic fibrosis treatment centers: an analysis of 1,051 recent sputum isolates

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Microbiology of sputum from patients at cystic fibrosis centers in the United States

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Endemicity and inter-city spread of Burkholderia cepacia genomovar III in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Comparison of two commercial systems (Vitek and MicroScan-WalkAway) for antimicrobial susceptibility testing of Pseudomonas aeruginosa isolates from cystic fibrosis patients.

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Effect of inhaled tobramycin on early Pseudomonas aeruginosa colonisation in patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Clinical outcome after early Pseudomonas aeruginosa infection in cystic fibrosis.

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Ward floors and other surfaces as reservoirs of hospital infection

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Surface disinfection: should we do it?

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

A common source outbreak of Acinetobacter pulmonary infections traced to Wright respirometers

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Outbreak of Enterobacter cloacae related to understaffing, overcrowding, and poor hygiene practices

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Nosocomial Legionnaires' Disease Caused by Aerosolized Tap Water from Respiratory Devices

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Home nebulizer use among patients with cystic fibrosis.

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Institutional outbreaks of rotavirus diarrhoea: potential role of fomites and environmental surfaces as vehicles for virus transmission

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Transmission of Mycobacterium tuberculosis by a fiberoptic bronchoscope. Identification by DNA fingerprinting

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Patient-to-patient transmission of hepatitis C virus during colonoscopy

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Levels of microbial contamination on surgical instruments

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Association of contaminated gloves with transmission of Acinetobacter calcoaceticus var. anitratus in an intensive care unit

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Variable morbidity of respiratory syncytial virus infection in patients with underlying lung disease: a review of the PICNIC RSV database. Pediatric Investigators Collaborative Network on Infections in Canada.

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Role of respiratory syncytial virus in early hospitalizations for respiratory distress of young infants with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Effect of respiratory virus infections including rhinovirus on clinical status in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Association of respiratory viral infections with pulmonary deterioration in patients with cystic fibrosis.

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Infection control: reducing the psychological effects of isolation.

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Emotional reactions of children to isolation in a cancer hospital

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Does isolation of patients with infections induce mental illness?

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

The psychological consequences of source isolation: a review of the literature

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Cluster of cases of invasive aspergillosis in a transplant intensive care unit: evidence of person-to-person airborne transmission.

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Allergic bronchopulmonary aspergillosis in cystic fibrosis. A European epidemiological study. Epidemiologic Registry of Cystic Fibrosis.

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Allergic bronchopulmonary aspergillosis in cystic fibrosis: reported prevalence, regional distribution, and patient characteristics. Scientific Advisory Group, Investigators, and Coordinators of the Epidemiologic Study of Cystic Fibrosis

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Clinical significance of Scedosporium apiospermum in patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Effect of chronic intermittent administration of inhaled tobramycin on respiratory microbial flora in patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Three cases of pulmonary aspergilloma in adult patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Infections in patients with cystic fibrosis following lung transplantation.

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Epidemiology of chronic Pseudomonas aeruginosa infections in the airways of lung transplant recipients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Infection with Burkholderia cepacia in cystic fibrosis: outcome following lung transplantation

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Lack of transmission of mycobacterium abscessus among patients with cystic fibrosis attending a single clinic

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Nontuberculous mycobacteria. I: multicenter prevalence study in cystic fibrosis.

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Non-tuberculous mycobacteria in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Lung transplantation in cystic fibrosis: consensus conference statement

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Annual influenza vaccination: immune response in patients over 10 years.

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Acute severe deterioration in cystic fibrosis associated with influenza A virus infection

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Impact of influenza on morbidity in children with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Purified fusion protein vaccine protects against lower respiratory tract illness during respiratory syncytial virus season in children with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Nontuberculous Mycobacteria in Adult Patients with Cystic Fibrosis

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Mycobacterial isolations in young adults with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

An outbreak of mycobacterial furunculosis associated with footbaths at a nail salon

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Nosocomial outbreaks/pseudo-outbreaks caused by nontuberculous mycobacteria

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Diagnosis and Treatment of Disease Caused by Nontuberculous Mycobacteria

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Identification and antimicrobial susceptibility of Alcaligenes xylosoxidans isolated from patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Bacterial colonisation with Xanthomonas maltophilia--a retrospective study in a cystic fibrosis patient population.

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Controlled study of Pseudomonas cepacia and Pseudomonas maltophilia in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Xanthomonas maltophilia misidentified as Pseudomonas cepacia in cultures of sputum from patients with cystic fibrosis: a diagnostic pitfall with major clinical implications.

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Stenotrophomonas maltophilia infection in children

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Nonrespiratory Stenotrophomonas maltophilia infection at a children's hospital

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Transmissibility and infection control implications of Burkholderia cepacia in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

An epidemic Burkholderia cepacia complex strain identified in soil

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Burkholderia cepacia complex bacteria from clinical and environmental sources in Italy: genomovar status and distribution of traits related to virulence and transmissibility

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Burkholderia cepacia genomovar III Is a common plant-associated bacterium.

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

The pseudomonas hot-foot syndrome

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Outbreak of severe Pseudomonas aeruginosa infections caused by a contaminated drain in a whirlpool bathtub

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

An episodic outbreak of genetically related Burkholderia cepacia among non-cystic fibrosis patients at a university hospital.

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Airborne dissemination of Burkholderia (Pseudomonas) cepacia from adult patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Microbiology of lung infection in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

An epidemic of burkholderia cepacia transmitted between patients with and without cystic fibrosis

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Comparative hygienic surveillance of contamination with pseudomonads in a cystic fibrosis ward over a 4-year period

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Epidemiology of Pseudomonas aeruginosa infection and the role of contamination of the environment in a cystic fibrosis clinic

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Pseudomonas aeruginosa cross-colonization and persistence in patients with cystic fibrosis. Use of a DNA probe

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Acquisition of Pseudomonas cepacia at summer camps for patients with cystic fibrosis. Summer Camp Study Group

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Cross infection between cystic fibrosis patients colonised with Burkholderia cepacia

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Outcome of Burkholderia (Pseudomonas) cepacia colonisation in children with cystic fibrosis following a hospital outbreak

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Gender gap in cystic fibrosis mortality

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Factors associated with poor pulmonary function: cross-sectional analysis of data from the ERCF. European Epidemiologic Registry of Cystic Fibrosis

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Respiratory infections with Pseudomonas aeruginosa in children with cystic fibrosis: early detection by serology and assessment of risk factors

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Acceleration of lung disease in children with cystic fibrosis after Pseudomonas aeruginosa acquisition

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Early bacteriologic, immunologic, and clinical courses of young infants with cystic fibrosis identified by neonatal screening

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Methicillin-resistant Staphylococcus aureus: impact at a national cystic fibrosis centre

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Predictive 5-year survivorship model of cystic fibrosis

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Determinants of mortality from cystic fibrosis in Canada, 1970-1989.

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Survival following Burkholderia cepacia sepsis in a patient with cystic fibrosis treated with corticosteroids.

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Pseudomonas cepacia infection in cystic fibrosis: an emerging problem

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Epidemiology of Burkholderia cepacia complex in patients with cystic fibrosis, Canada

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Spread of an epidemic Pseudomonas aeruginosa strain from a patient with cystic fibrosis (CF) to non-CF relatives

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Epidemiology of Pseudomonas aeruginosa in cystic fibrosis in British Columbia, Canada.

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Vancomycin-resistant Staphylococcus aureus: perspectives on measures needed for control

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Are the epidemiology and microbiology of methicillin-resistant Staphylococcus aureus changing?

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Clonal features of community-acquired methicillin-resistant Staphylococcus aureus in children.

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Genome and virulence determinants of high virulence community-acquired MRSA

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Epidemiology and clonality of community-acquired methicillin-resistant Staphylococcus aureus in Minnesota, 1996-1998.

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Current trends in community-acquired methicillin-resistant Staphylococcus aureus at a tertiary care pediatric facility.

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Burkholderia cepacia complex genomovars and pulmonary transplantation outcomes in patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Effect of Hand Cleansing with Antimicrobial Soap or Alcohol-Based Gel on Microbial Colonization of Artificial Fingernails Worn by Health Care Workers

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Epidemiology Of Chronic Pseudomonas aeruginosa Infections In Cystic Fibrosis

1 reference

https://api.crossref.org/works/10.1086%2F503485

21 January 2018

Identifiers

1 reference

Europe PubMed Central

9 April 2018

http://europepmc.org/abstract/MED/12789902

1 reference

Europe PubMed Central

9 April 2018

http://europepmc.org/abstract/MED/12789902

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51669881&oldid=1218482487"